5429192025-10-012025-12-315429192025-04-012025-12-315429192025-10-012025-12-31in-capmkt:OtherExpenses1Member5429192025-04-012025-12-31in-capmkt:OtherExpenses1Member5429192025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15429192025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25429192025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15429192025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares542919ARTEMISMEDNOTLISTEDINE025R01021ARTEMIS MEDICARE SERVICES LIMITEDMain BoardEquity2025-04-012026-03-312026-02-022026-01-28INRLakhsQuarterlyThird quarterSingle segmentHealthcare Services2026-02-0216:00:002026-02-0218:10:00Not applicable2025-10-012025-12-31UnauditedConsolidated2723523000746010002798124000641055000004342420006745900012443400012025380002469728000328396000-3074400029765200064775000105330007530800002223440000000222344000-3364000218980000223399000-1054000220064000-108300015830600011.411.41001.411.41The value of Earning per share for the quarter/ nine months is not annualised. <BR> <BR> Notes: <BR> <BR> 1. The above unaudited Consolidated financial results of Artemis Medicare Services Limited (the Company) and one Subsidiary Company (together referred as 'the Group') for the quarter and nine months ended December 31, 2025, have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on February 02, 2026. The financial results were subject to limited review by the statutory auditors, T R Chadha & Co LLP and the review report is unmodified. <BR> <BR> 2. The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended (Ind AS), as prescribed under Section 133 of the Companies Act 2013 (the 'Act') read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended) and the other recognised accounting practices and policies to the extent applicable and is in compliance with presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). <BR> <BR> Please refer remaining notes from unaudited financial results filed in PDF format.2025-04-012025-12-31UnauditedConsolidated802016000022042400082405840001934308000001210997000213135000353113000350903300072205860001019998000-307440009892540002142240004068900025491300007343410000000734341000-4856000729485000735874000-1532000731072000-158700015830600014.664.66004.664.66Other Expenses1202538000Other Expenses3509033000Remeasurement gain/(loss) of defined employee benefit plans-5969000Deferred Tax adjustment on revaluation that will not be reclassified to profit or loss1102000-4867000Remeasurement gain/(loss) of defined employee benefit plans-10906000Deferred Tax adjustment on revaluation that will not be reclassified to profit or loss3304000-7602000-1503000-2746000-3364000-4856000